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Characterization of a Serine Protease that
Cleaves Pro--Melanotropin at the Adrenal
to Stimulate Growth
(Estivariz et al., 1982; Rao et al., 1978). This evidence
suggests that the decreased corticosteroid levels lead
to an upregulation of POMC expression and the POMC-
derived mitogens. There is a considerable body of evi-
dence to suggest that the mitogenic POMC peptides
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reside in the so-called 16 kDa fragment (also calledThe University of Reading
pro--MSH). Although this peptide has no mitogenicWhiteknights
properties per se, it has been shown that N-terminalPO BOX 228
peptides derived from it not containing the -MSH se-Reading, Berkshire, RG6 6AJ
quence have potent mitogenic actions on isolated adre-United Kingdom
nal cells in vitro (Estivariz et al., 1982) and that synthetic2 McGill University, Montreal
N-POMC (1–28) increases proliferation of the Y1 adreno-Canada
cortical cell line (Fassnacht et al., 82nd Meeting of Endo-
crine Society, Toronto, Canada, P864). As the molecular
form that is secreted from the pituitary corticotroph isSummary
pro--MSH, it has been suggested that this peptide un-
dergoes a postsecretional cleavage resulting in the gen-The adrenal gland requires stimuli from peptides de-
eration of these smaller N-POMC peptides at or nearrived from the ACTH precursor, pro-opiomelanocortin
the growing gland (Estivariz et al., 1982; Lowry et al.,(POMC), to maintain its tonic state. Studies have pro-
1983). Circumstantial evidence for this hypothesisposed that a specific postsecretional cleavage of the
comes from studies in sheep during the period of rapidnonmitogenic N-terminal 16 kDa fragment, also known
adrenal growth toward the end of gestation when it wasas pro--melanotropin (pro--MSH), is required, re-
shown that concentrations of pro--MSH fall dramati-leasing shorter fragments that promote adrenal
cally with a corresponding rise in the levels of shortergrowth. Here, we provide evidence for this hypothesis
N-POMC peptides (Saphier et al., 1993). This has re-by the cloning and characterization of a serine prote-
cently been confirmed by Ross et al. (2000) who showedase that is upregulated during growth of the adrenal
that infusion of pro--MSH into sheep during this periodcortex. It is expressed exclusively in the outer adrenal
results in a significant increase in adrenal size. However,cortex, the site of cell proliferation, and in the Y1 adre-
the most compelling evidence for this hypothesis hasnal cell line. We also show that it is required for growth
come from the study of the adrenal phenomenon ofof Y1 cells, remains bound to the cell surface, and
compensatory growth. Following unilateral adrenalec-cleaves its substrate, pro--MSH, at a specific bond.
tomy, the remaining adrenal undergoes a period of rapid
growth as measured by increases in mass, DNA, andIntroduction
RNA content (Dallman et al., 1976, 1980; Lowry et al.,
1983; Pellegrino et al., 1963). Extensive studies haveCloning of the cDNA encoding the complete structure
indicated that this process is neurally mediated by theof the ACTH precursor POMC revealed it to encode a
activation of afferent nerve connections from the adrenalnumber of other potential peptide hormones (Nakanishi
to the hypothalamus (Dallman et al., 1976, 1980). Indeed,et al., 1979) that would be cosecreted with ACTH during
pinching of the adrenal pedicle, inducing temporarythe stress response. This, however, posed the question
ischemia, is sufficient to stimulate the response in the
of how their biological actions, e.g. on adrenal growth,
contralateral gland (Dallman et al., 1976), and this has
could be differentially regulated distinct from that of
been shown to be mediated by -adrenergic receptors
ACTH-induced adrenal corticosteroidogenesis. in a negative fashion (Holzwarth, 1988). Many of these
The adrenal gland is a dynamic organ with respect to studies dismiss a hormonal role in the process on the
growth in that it requires constant stimuli from POMC- grounds that it has been demonstrated that the re-
derived peptides since either hypophysectomy (Vinson sponse still occurs in hypophysectomized or corticoste-
et al., 1985) or suppression of POMC peptide secretion roid suppressed animals (Dallman et al., 1980; Lipscomb
by treatment with dexamethasone (Bransome, 1968; and Critchlow, 1968; Dunlap and Grizzle, 1984) while
Wright et al., 1974) results in rapid adrenal atrophy. Fur- exogenous ACTH administration actually inhibits the re-
thermore, POMC peptides play a vital role in adrenal sponse (Dallman et al., 1980). However, the data pre-
development as targeted disruption of the POMC gene sented in these studies must be viewed with some de-
results in the complete absence of adrenal tissue (Yas- gree of caution since the so-called growth response is
wen et al., 1999). Although ACTH has often been re- occurring at a time when the adrenal gland is undergoing
garded to be the POMC peptide that promotes mitogen- rapid atrophy. Indeed, it has been clearly demonstrated
esis, evidence from in vitro studies suggests that ACTH that the peptides derived from the N terminus of POMC
is anti-mitogenic (Hornsby, 1984) while in vivo immuno- play a crucial role in eliciting the compensatory growth
neutralization of circulating ACTH, although significantly response (Lowry et al., 1983). Using antisera to immuno-
decreasing corticosteroid levels, increases mitogenesis neutralize specific circulating POMC peptides, it was
shown that the extreme N-terminal peptides and not
ACTH were essential in eliciting the growth response,3 Correspondence: a.b.bicknell@rdg.ac.uk
Cell
904
Figure 1. Proteolysis Is Required for Growth Both In Vivo and In Vitro
(A) Effect of trasylol on the growth response of the contralateral gland following left unilateral adrenalectomy (UAdx). A significant increase
(P  0.001) in adrenal size 24 hr post UAdx (black bar) compared to the size of the adrenal removed (white bar) was observed in the saline-
treated group (n  15). However, the sham controls (n  10) and those pretreated with trasylol (n  13) showed no significant compensatory
growth response.
(B) Effect of trasylol on growth of the mouse Y1 adrenocortical cell line. Cells were grown in 5% Optimem diluted in MEM with (black bars)
or without (white bars) the addition of 350 KIU/ml of trasylol. Significant differences (P  0.001) were observed in the trasylol-treated group
on all but day one.
adding weight to the argument that the mitogenic POMC consequently investigated expression of this family of
enzymes in the adrenal using PCR with degenerate oli-peptide resides in the N-terminal fragment. However, a
gonucleotides designed around the catalytic histidinesurprising result from this study was the finding that
and serine residues. Using adrenal cDNA derived fromimmunoneutralization against N-POMC (50–74) (3-
both normal and glands undergoing compensatoryMSH) completely inhibited the compensatory growth
growth as template, an autoradiograph was obtained,response. As this peptide has no mitogenic properties
shown in Figure 2A. The sequence of the clones derivedand that its precursor pro--MSH is the principal circu-
from band 1 was identified as tissue plasminogen activa-lating form, it was postulated that this precursor peptide
tor, which has previously been identified in the adrenalwas specifically cleaved postsecretionally by a protease
medulla (Kristensen et al., 1986). The sequence of clonesexpressed by the adrenal giving the shorter, mitogenic
derived from band 2 did not match any known sequence,N-POMC peptides, and it was this cleavage that was
while clones from band 3 were identified as adipsin, (Minbeing inhibited by the binding of the -MSH antibody
and Spiegelman, 1986). Its expression in the adrenal hasto pro--MSH (Lowry et al., 1983).
not been previously reported, but investigation using inHowever, to date, this putative protease has not been
situ hybridization showed expression across both zonaeidentified. In this study, we investigate the role of proteo-
fasciculata and reticularis (results not shown). As thelysis in compensatory growth resulting in the cloning
blood in the adrenal is centripetal and mitogenesis oc-and characterization of a serine protease that fulfills the
curs in a narrow band of cells underneath the capsule,requirements of the hypothesis.
adipsin is unlikely to be involved directly in adrenal
growth.Results
We investigated the unknown sequence further, and
the full-length coding sequence, together with the de-Investigation into the Role of a Serine
duced amino acid sequence, is shown in Figure 2B andProtease in Adrenal Growth
can be accessed via GenBank accession numberTo investigate the hypothesis that a protease was in-
AF198087.
volved with adrenal growth, we tested the effects of the
Analysis of the sequence indicates it to contain two
serine protease inhibitor aprotinin on the compensatory
putative ATG start codons; the first, at position 16, does
growth response. The results, shown in Figure 1A, show
not contain a Kozak translation intitation sequence (Ko-
the expected growth response in the saline-injected uni-
zak, 1987) and also has an in-frame stop codon starting
lateral adrenalectomized group (P  0.001) while no
at position 28. The second ATG at position 32 has a
significant growth was observed in the sham-operated Kozak sequence and encodes a putative 279 amino acid
controls or in the group pretreated with aprotinin, sug- protein of predicted 30.5 kDa molecular weight con-
gesting that a protease is involved with the growth re- taining the conserved His/Asp/Ser catalytic triad (resi-
sponse. Additionally, aprotinin significantly reduced the dues 88, 133, and 229, respectively) typical of the trypsin
growth rate of Y1 cells grown in 5% Optimem (Figure family of enzymes. The enzyme also contains an aspartic
1B) when compared to controls, suggesting proteolysis acid residue at the 6 position from the catalytic serine
was also required for their growth. which is known to confer specificity for basic residues
(Ruhlmann et al., 1973; Bode et al., 1984). The sequence
Molecular Cloning of a Serine Protease contains no putative N-linked glycosylation sites. Com-
As aprotinin is unlikely to penetrate the cells, we rea- puter analysis of the sequence using the PSort program
soned that the putative protease would be likely to be accessed at http://psort.nibb.ac.jp (Nakai and Kanehisa,
1992) predicts it to contain a potential N-terminal signala member of the trypsin family of serine proteases. We
Cloning of a Mitogenic Adrenal Serine Protease
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Figure 2. Cloning of a Serine Protease
(A) Autoradiogram of PCR products amplified from adrenal cDNA with degenerate oligonucleotides designed around the conserved catalytic
His/Ser residues of the trypsin family of serine proteases. Band 1 was identified as tissue plasminogen activator (tPA), band 2 as an unknown
sequence, and band 3 as adipsin.
(B) Nucleotide and deduced amino acid sequence of AsP. The deduced amino acid sequence starts from the second ATG codon, which
satisfies the criteria for a Kozak initiation sequence. Nucleotides are numbered on the left margin and amino acids on the right.
(C) Comparisons of the deduced amino acid sequence of the catalytic portion of AsP (residues 48–279) with that of other serine proteases
in the trypsin family. Identical amino acids are shaded and the catalytic triad of histidine, aspartic acid, and serine are marked by a *.
sequence (residues 1–22, P  0.88), indicating the en- below) of this enzyme may make this protection against
autolysis unnecessary.zyme to be directed to the secretory pathway and thus
likely secreted. In light of the computer prediction, we
named the enzyme AsP for Adrenal secretory Protease. Tissue Distribution and Expression of AsP
during Compensatory GrowthComparison of the sequence with that of other members
of the trypsin family (Figure 2C) revealed it to possess To determine the tissue distribution of AsP, we used
PCR to amplify a fragment of the gene from cDNAshigh homology to the catalytic region of human airway
trypsin-like protease (HAT) (Yamaoka et al., 1998). This synthesized from various adult rat tissues together with
the Y1 mouse adrenal cell line. Although the number ofserine protease is considerably larger than AsP and con-
tains an N-terminal hydrophobic transmembrane do- tissues listed is not exhaustive, the results (Figure 3A)
suggest that expression is limited to the adrenal andmain not shared by AsP, raising the possibility that AsP
may be a splice variant of HAT. However, extensive also the Y1 cell line. To confirm upregulation of AsP
mRNA expression during compensatory growth, wesearching of the available public databases revealed the
genomic sequence of HAT on chromosome 16, but the used a semi-quantitative PCR method in which a 10-
fold serial dilution of adrenal cDNA templates is usedgene does not appear to code for the unique N-terminal
portion of AsP, strongly suggesting that AsP is encoded to estimate the relative levels of a specific cDNA. The
results from this experiment can be seen in Figure 3B.from a separate gene. Homology also suggests that AsP
may contain a cleavable activation peptide (most likely The PCR successfully amplified a fragment from the
undiluted and the 1:10 dilution in the sham-operatedfrom residues 23–47) containing a single cysteine resi-
due that would ensure it remains attached after cleavage animals while in the adrenalectomized animals, the
1:100 template was also successfully amplified, indicat-in a similar manner to chymotrypsin (Brown and Hartley,
1966). However, the narrow substrate specificity (see ing AsP expression to be approximately 10-fold upregu-
Cell
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Figure 3. Analysis of AsP Expression
(A) Tissue distribution of AsP determined using PCR with specific AsP oligonucleotide primers. The presence of the 461 bp band indicates
expression to be limited to the adrenal and Y1 adrenal cortical tumor cell line.
(B) PCR analysis of AsP gene expression in the rat adrenal. Reactions were set up with a 10-fold serial dilution of template cDNAs in order
to assess the relative expression levels of AsP in sham-operated and in the contralateral gland 24 hr post UAdx. PCR successfully amplified
the 1:100 dilution of the adrenalectomized cDNA, but only the 1:10 dilution of the sham-operated cDNA, indicating AsP expression to be
approximately 10-fold upregulated following UAdx. Tissue plasminogen activator (tPA) was used as a control to standardize reactions,
demonstrated by the successful amplification of the same range of cDNA templates.
lated. The PCR specific for tPA amplified the undiluted ing compensatory growth, expression can be seen to
be limited to the outer zona fasciculata/glomerulosa1:10 and 1:100 templates in both the sham and adrenal-
ectomized cDNAs, indicating normalization of the cDNA boundary with a negative centripetal gradient.
templates.
Role of AsP in Growth of the Y1 Cell Line
The role of AsP in adrenal growth was investigated byIn Situ Hybridization
Expression of AsP within the adrenal was investigated generating stable Y1 cell lines expressing sense and
antisense mRNA (confirmed by PCR) designed to modu-using in situ hybridization on adrenal sections cut from
both sham-operated and 24 hr post unilateral adrenalec- late the expression of endogenous AsP. Immunoblotting
of total cell lysates with the affinity-purified AsP antibodytomized animals with sense and antisense riboprobes.
The sections were analyzed using confocal microscopy (Figure 5A) detected a single band of the predicted mo-
lecular weight, showing that AsP expression was de-and typical images are shown in Figure 4.
AsP expression appears to be limited to the adrenal creased by approximately half in the cells expressing
antisense RNA compared to sense cells. The immunore-cortex with no significant expression in the adrenal me-
dulla. Within the cortex, particularly in adrenals undergo- activity of this band was completely abolished by pre-
Figure 4. Expression of AsP in the Rat Ad-
renal
Localization of AsP expression in the normal
rat adrenal (A) and in the contralateral gland
following UAdx (B). Expression of mRNA en-
coding AsP is shown by in situ hybridization
and confocal microscopy, indicated by the
green images in the left-hand plate. Cell nu-
clei are shown in red in the central plate. The
images are superimposed in the right-hand
plate to clarify the regional expression of AsP.
Control sections (C) were hybridized with a
sense probe to confirm specific hybridization.
(ZG—zona glomerulosa; ZF—zonafasciculata).
Cloning of a Mitogenic Adrenal Serine Protease
907
Figure 5. AsP Is Required for the Growth of Y1 Cells
Y1 cells were stably transfected with constructs designed to reduce the expression level of endogenous AsP. (A) PCR was used to detect
expression of the constructs and Western blotting confirmed that AsP expression was reduced. Sense (white bars) and antisense AsP RNA
(black bars) were grown in (B) media containing FCS and (C) in Optimem (5% v/v) diluted in MEM. No difference in growth rate was observed
in media containing FCS, but sense cells grew significantly faster in 5% Optimem (P  0.001 on all but day one) than antisense cells.
(D) Effect of pro--MSH on the growth of sense and antisense cells. No difference in the growth rate was observed in the sense cells grown
either without (white bars) or with the addition of 10 nM pro--MSH (black bars). However, the total number of cells obtained by the pro--
MSH treated group was significantly higher (P  0.001). No difference in the rate of growth or total number of cells was observed with
antisense cells grown either without (hatched bars pointing down) or with (hatched bars pointing up) the addition of pro--MSH.
(E) Effect of affinity stripping Optimem media of -MSH containing peptides. The growth rate of the sense cells (white bars) was reduced to
that of the antisense cells (black bars). Cells grown in Optimem passed through the control NSS column grew at a similar rate to those in (C)
(results not shown).
incubation of the antibody with AsP (23–47) peptide. The of the sense cells was reduced to that of the antisense
cells. In addition, there was no difference in the growthgrowth rate of these clones was found to be identical in
normal growth media containing fetal calf serum (Figure rate of the latter in -MSH-depleted media compared
to control media. These results strongly support the5B), indicating that transfection of the constructs was
not deleterious in this media. However, when cells were notion that pro--MSH is the substrate for AsP.
grown in 5% Optimem, a medium that contains POMC
peptides, the antisense cells grew at a significantly re- Molecular Modeling
Using the known crystal structures of trypsin and chy-duced rate (Figure 5C), suggesting that AsP expression
is required for growth of Y1 cells. In order to establish motrypsin, we generated a putative model of AsP.
Shown in Figure 6A, the binding pocket and active siteif pro--MSH was the substrate for AsP, we grew the
sense and antisense cells in the presence of 10 nM can be clearly seen. Two interesting features revealed
by the model are an arginine residue (position 130) pro-bovine pro--MSH. The results from this experiment
shown in Figure 5D show that the addition of the peptide truding into one end of the binding pocket, suggesting
this may play a role in substrate specificity, and, sec-had no effect on the actual rate of growth of the sense
cells, but allowed a significantly greater final cell number ondly, the model displays a large number of arginine
residues (shown in blue) on the opposite face to theto be obtained. In contrast, the peptide had no effect on
either the rate of growth or the final number of antisense active site. This latter feature is interesting since it would
lead to a concentration of positive charge on this face,cells. When the sense and antisense cells were grown
in -MSH-depleted media (Figure 5E), the growth rate which may well interact with negatively charged cell
Cell
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Figure 6. AsP Is Retained on the Surface of
Y1 Cells following Secretion
(A) Graphical representation of the 3D struc-
ture of AsP generated using homology mod-
eling. A cluster of arginine residues (shown
in blue and labeled (A)) can be clearly seen
posterior to the binding pocket (B) and were
hypothesized to retain AsP on the cell surface
following secretion. The model also predicted
a single arginine residue in the bottom of the
binding pocket that may contribute to sub-
strate specificity.
(B) Localization of AsP in Y1 cells using immu-
nocytochemistry. Cells were not treated with
detergent such that only protein on the sur-
face of the cell was detected. AsP detected
by an anti-AsP antibody in cells expressing
the sense construct localizes to the cell sur-
face (A) in contrast to the low expression ob-
served in cells expressing the antisense con-
struct (B). Localization was further confirmed
by overexpressing AsP in Y1 cell tagged at the
C terminus with the octapeptide FLAG se-
quence and detected with a monoclonal anti
FLAG antibody directly coupled to HRP (C).
surface moieties found on the cell surface, potentially reduced and nonreduced forms. It is interesting to note
that this active, secreted form of AsP still retained theretaining it on the cell surface following secretion. To test
this latter hypothesis, we initially examined endogenous N-terminal epitope after reduction, indicating that it is
synthesized and secreted in an active form.AsP expression with the AsP antibody. Immunocyto-
chemistry on nondetergent-treated cells to avoid detec-
tion of intracellular AsP (Figure 6B) showed expression
Discussion
of AsP localized to the cell surface, with greater expres-
sion apparent in the sense cells. These results were
In this study, we have attempted to investigate how the
further confirmed by overexpressing full-length AsP
specific adrenal growth factor is derived from POMC.
tagged at the C terminus with the octapeptide FLAG
To this end, we have shown that proteolysis is required
sequence in Y1 cells (Figure 6B).
for both the compensatory growth response seen after
unilateral adrenalectomy and for the growth of the Y1
adrenocortical cell line. As it is unlikely that aprotininActivity and Specificity of AsP
To demonstrate that the sequence near the Arg/Lys at can exert its actions within the cell, it seems that the
putative protease was likely to be secreted and either49/50 is the target POMC sequence, we incubated sense
and antisense cells with an internally quenched fluores- released into the microcirculation of the adrenal or re-
main attached to the cell surface. We have confirmedcent peptide, QFS-20. The results (Figure 7A) showed
a 1.7 times activity increase in the sense cells compared this by characterizing a serine protease (AsP) which is
expressed in the cellular layer known to be responsibleto the antisense cells. However, no activity was detected
in either the sense or antisense cells incubated with for the derivation of cortical tissue (Estivariz et al., 1992;
Morley et al., 1996). Homology modeling predicted thateither the classical trypsin substrate Boc-Arg-MCA or
with the Boc-Gln-Arg-Arg-MCA peptide (results not AsP was retained on the cell surface, and this was con-
firmed using immunocytochemistry on Y1 cells with anti-shown), suggesting that AsP is not a broad spectrum
protease either at mono or dibasic sites. bodies raised against a synthetic N-terminal peptide
fragment of AsP, as well as with overexpressed epitope-Using the AsP antibody coupled to Sepharose to affin-
ity purify the enzyme released from the cell surface into tagged AsP.
The physiological role of AsP in adrenal cell growththe media, no activity was purified from unconditioned
media, but enzyme purified from conditioned media rap- was demonstrated by Y1 cells expressing sense and
antisense AsP mRNA. It was not unexpected that noidly cleaved QFS-20 (1.5 mol was completely cleaved
in 15 min). The cleavage point was determined by mass difference was observed when these cells were grown
in media containing fetal serum, as the serum wouldspectrometry, which gave one major peak of 1249.8 Da
equating to Abz-L-T-E-N-P-R-K-Y-V (Figure 7B). Once have been harvested from animals at a time of rapid
adrenal growth and would contain high circulating con-the cleavage experiments were completed, AsP was
eluted with low pH and analyzed by Western blotting centrations of N-POMC fragments (Saphier et al., 1993)
as well as other growth factors. However, when the cellswith the AsP antibody. The results of this indicated the
presence of one major immunoreactive product of ap- were grown in media containing a more defined medium
(5% Optimem) known to contain pituitary POMC pep-proximately 28 kDa (Figure 7C), concomitant with the
expected size of AsP, the slight difference in apparent tides, the antisense cells grew significantly slower than
the sense cells, providing clear evidence that AsP issize being due to the difference in mobility between the
Cloning of a Mitogenic Adrenal Serine Protease
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Figure 7. AsP Cleaves Pro--MSH to Release the Mitogenic Fragment N-POMC (1–52)
(A) Proteolytic activity on the surface of sense and antisense cells toward the quenched fluorescent POMC peptide QFS-20. Sense cells had
significantly more (P  0.001) activity toward the peptide than antisense cells.
(B) AsP affinity purified from cell media bound to solid phase AsP antibody rapidly cleaved QFS-20. Mass spectrometry showed a major peak
at 1249.8 (Abz-LTENPRKYV), with minor fragments corresponding to the masses of QFS-20 (1–6), (1–7), (1–8), and (1–10).
(C) Western blot to confirm the identity of AsP eluted from the solid phase antibody.
involved with the growth of these cells. The finding that Taken together, the data present AsP as a strong
candidate for the protease that cleaves pro--MSH dur-the growth rate of the sense cells in media supple-
mented with pro--MSH was not increased but resulted ing adrenal growth, the implications of which are signifi-
cant as it gives the adrenal the ability, by regulation ofin an increase in the total number of cells indicates that
the growth rate of the cells is not initially limited by the AsP expression, to control its tonic state independent
of the steroidogenic stimuli elicited by ACTH. This raisessupply of mitogenic POMC peptides. However, the fact
that only the sense cells could utilize the additional pro- the interesting question as to the control of AsP gene
expression in both the normal and growing gland.-MSH suggests that AsP is required to release its mito-
genic activity. To further support this, Optimem depleted Another area of interest is the role AsP plays during
adrenal development. The results of fetal sheep studiesof -MSH peptides had the effect of reducing the growth
rate of the sense cells to that of the antisense cells, (Ross et al., 2000; Saphier et al., 1993) and those from the
POMC knockout mouse (Yaswen et al., 1999) stronglybut did not alter the rate of the latter, again strongly
suggesting that AsP specifically activates the mitogenic suggest that N-POMC peptides are essential for normal
fetal adrenal development.activity of its specific substrate pro--MSH.
The homology model also suggested that due to an The recent observation that the melanocortin receptor
antagonist agouti related protein (AgRP) is significantlyarginine residue in the binding pocket, the potential sub-
strate would require a negatively charged residue close upregulated in the adrenal cortex during compensatory
growth (Bicknell et al., 2000) raises the possibility thatto its cleavage site. This latter observation is supported
by the finding that sense cells expressed greater cleav- this may play a role in suppressing steroidogenesis dur-
ing growth by blocking adrenal melanocortin receptors.age activity compared to antisense cells toward the
POMC model peptide, QFS-20, which contains a glu- This, together with the cleavage of pro--MSH, may
finally provide the answers as to how the diverse rangetamic acid residue. However, the cells show no detect-
able activity toward the more general model peptide of biological activities contained within this classical
substrates Arg-MCA or Gln-Arg-Arg-MCA, suggesting hormone precursor are controlled. Finally, for N-POMC
that the bulky positively charged arginine residue at the (1–52) to exert its mitogenic actions, there must be an
end of the binding pocket results in AsP being highly unidentified receptor on the target adrenocortical cells.
specific for peptides with an acidic residue near the
cleavage site. We further supported these observations
Experimental Proceduresby using solid phase AsP antibody to purify AsP from
cell media and found that the purified enzyme rapidly Animal Models
cleaved the N-POMC substrate QFS-20 at the valine- All animal procedures were carried out according to the Animal
methionine bond, two residues downstream from the (Scientific Procedures) Act 1986.
Unilateral adrenalectomy was performed by removal of the left-dibasic site at 49/50 (which is cleaved in the pars inter-
hand adrenal via a dorsal approach from groups of male NEDHmedia), leading to the conclusion that the natural adrenal
strain rats (150 g) anaesthetized with halothane. The animals weremitogenic fragment is POMC (1–52). This C terminally
allowed to recover and sacrificed 24 hr post operation, at whichextended N-POMC peptide may also answer the ques-
time the remaining right-hand adrenal was removed and either used
tion of why mitogenic activity is not associated with the for RNA extraction or frozen on dry ice for sectioning. Sham controls
pars intermedia (Lowry et al., 1983) nor POMC (1–49) were produced in an identical manner except that the left adrenal
was not removed at surgery.purified from it (Ross et al., 2000).
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Growth of the Y1 Adrenocortical Cell Line length coding sequence was amplified using two gene-specific
primers, (at the 5 end of the gene from positions 3–29, 5GTCACTAll cell culture reagents were obtained from Sigma. Cells were main-
tained in a humidified incubator at 37	C, 5% CO2 and grown in Hams GAGCCTCATGAAATCAGGGTG3 and at the 3 end of the gene from
positions 922–896, 5AGGCACTTGGGTACAGACTTCACGGGA3)F10 supplemented with 15%(v/v) FCS, 100 U/ml of penicillin, 100
g/ml of streptomycin, 2 mM L-glutamine, and 100 g/ml G418 if with reactions conditions as described and cycled as follows: initial
denaturation of 94	C for 1 min then 35 cycles of 94	C for 30 s andtransfected. Due to the large quantities of growth factors and POMC
peptides present in this media, growth experiments were carried 68	C for 2 min. The PCR product was analyzed by agarose gel
electrophoresis, cloned, and sequenced in both directions.out in a minimal media consisting of 5% (v/v) Optimem (Life Technol-
ogies) diluted in MEM supplemented with 2 mM L-glutamine plus Tissue distribution of the enzyme was determined by PCR to
amplify a specific 461 bp product using internal gene-specific prim-any treatment. Optimem media was used principally because it con-
tains N-POMC peptides (5 ng/ml as measured by RIA) and was ers (5 end of the gene from positions 158–183, 5CTGTCAGAAGA
GAGAATCATTGGAGG3 and at the 3 end of the gene from positionsdiluted 1 in 20 to obtain a more physiological concentration. Bovine
pro--MSH (POMC [1–77]) was purified as described previously 618–593, 5TCCGAACTTACTATTCTGACCTCTCC3) with reaction
conditions as described using cDNA synthesized from adrenal,(James and Bennett, 1985).
heart, liver, kidney, lung, brain, placenta, spleen, thymus, ovary,
testes, and the Y1 tumor cell line as template. Reactions were cycledEffects of Aprotinin on the Compensatory Growth Response
as follows: initial denaturation of 94	C for 1 min then 35 cycles ofand Growth of the Y1 Cell Line
94	C for 30 s and 68	C for 1 min.Groups of male rats (approximately 150 g) were injected intra perito-
Expression in the adrenal was determined using a semi-quantita-neally (i.p.) with either saline (n  15) or saline containing 80000 KIU
tive PCR method (Shutter et al., 1997) utilizing adrenal cDNA derivedof the serine protease inhibitor trasylol (n  13) (aprotinin, Bayer)
from sham-operated and 24 hr post unilateral adrenalectomized30 min before unilateral left adrenalectomy. Sham-operated controls
animals as template. Reactions were set up and cycled in an identi-(n  10) were also performed in which the left adrenal was not
cal method to those used to determine tissue distribution but usingremoved during surgery. Twenty four hours later, the animals were
a 10-fold serial dilution of template cDNA to assess the relativesacrificed and the right adrenal carefully removed and weighed.
expression levels by comparing the dilution at which the PCR prod-To investigate the effects of aprotinin on adrenal cells in vitro, Y1
uct became visible on an agarose gel. Template cDNA was standard-cells were seeded in six well dishes (in triplicate) and grown over-
ized by amplification, using identical conditions, of a 435 bp internalnight in normal growth media before being replaced (day 1) with
fragment of tissue plasminogen activator (tPA), an enzyme ex-5% Optimem containing either 350 KIU of trasylol per ml or the
pressed in the adrenal medulla (Kristensen et al., 1986).equivalent volume of saline. Cells were harvested on days 1, 2, 3,
4, and 5 by trypsinization and counted using a Coulter Counter.
In Situ Hybridization
Sense and antisense protease riboprobes (461 nt) labeled with di-
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goxygenin (DIG) were synthesized by in vitro transcription from the
Total RNA was extracted from rat adrenals using TRI reagent
PCR product derived from the tissue distribution cloned into pGEM-T
(Sigma), poly(A)
 RNA isolated using Oligotex latex beads (Qiagen),
Easy (Promega). After synthesis, probes were checked for integrity
and 1 g used to synthesize double-stranded Marathon Ready
by denaturing agarose gel electrophoresis and purified by selective
cDNA using the Marathon cDNA Amplification Kit (Clontech).
precipitation. In situ hybridization was carried out as previously
Degenerate oligonucleotide primers were designed to a consen-
described (Bicknell et al., 2000).
sus sequence surrounding the conserved Histidine and Serine resi-
dues in the catalytic triad of the trypsin family of serine proteases
Production of AsP Antibodycorresponding to the sequence at the N terminus, Q W V L T/S A
A rabbit polyclonal antibody was raised against the 25-mer peptideA H C (5CAR TGG GTN YTN WCN GCN GCN CAY TG3, and at
DQDTENVLTQECGARPDLITLSEER (Affiniti Research Products) cor-the C terminus, D A C Q G D S G G (5NCC NCC NGA RTC NCC
responding to residues 23–47 of the full-length translated productYTG RCA NGC RTC3) (Genosys Biotechnologies). These oligonu-
of AsP. The immunogen was made by reacting 1 mg of sulpho-cleotides were then used to prime PCR reactions utilizing adrenal
GMBS bifunctional coupling reagent (Pierce) with 4 mg of avian-cDNA synthesized from normal and adrenal glands undergoing
purified protein derivative (PPD) (Central Veterinary Agency) for 15growth following unilateral adrenalectomy as template. PCR reac-
min. The maleimmido derivatized PPD was purified on a Sephadextions were set up containing 40 mM Tricine-KOH (pH 9.2 at 25	C),
G25 gel filtration column and eluted directly onto 2 mg of peptide.15 mM KAc, 3.5 mM Mg(Ac)2, 75 g/ml BSA, 0.2 mM of each dNTP,
The conjugate was emulsified in complete Freund’s adjuvant and50 nM of  32P dATP (1000–3000 Ci/mmole, AmershamPharmacia),
used to immunize rabbits. Antibody titres were determined by add-0.2 M of each primer, approximately 10 ng of Marathon dscDNA,
ing a serial dilution of antiserum to the peptide coupled to Covalinkand 2.5 U of KlenTaq Advantage polymerase mix (Clontech). The
(GibcoBRL) 96 well plates (1g peptide per well). Following washingreactions were cycled as follows: initial denaturation of 94	C for 1.5
with saline, the bound antibody was detected using a HRP-conju-min then 30 cycles of 94	C for 30 s, 65	C for 30 s, and 68	C for 4
gated swine anti-rabbit antibody followed by colorimetric detection.min. The radiolabeled products were separated on a 5% denaturing
polyacrylamide gel (National Diagnostics) and bands visualized by
Affinity Purification of AsP Antibodyautoradiography. Bands of interest were excised and the DNA eluted
Peptide (500 g) coupled to Ultralink Iodoacetyl (Pierce) was usedin 50 l of water by boiling for 5 min. The DNA was purified using
to affinity purify AsP antibodies from 15 ml of rabbit antiserumthe GenecleanII kit (Bio101) and one fifth used as a template for
diluted 1:10 with saline. After washing the solid phase with 50 mMreamplification using the same reaction conditions, excluding the
sodium acetate/20% acetonitrile (pH 6), the antibody was elutedradioactivity. The products were analyzed by agarose gel electro-
from the column with 2 ml of 50 mM sodium acetate/formate buffer/phoresis, cloned, and sequenced.
20% acetonitrile (pH 4) and subsequently neutralized with 100 l ofFull-length coding sequence was obtained using the Marathon 5
saturated sodium bicarbonate. Solid phase antibody was made byand 3RACE system (Clontech) using the known sequence to design
coupling 250 g of the antibody to 200 mg cyanogen bromide acti-gene-specific oligonucleotide primers. For 5 RACE, the gene-spe-
vated Sepharose 4B (according to the manufacturers’ instructions,cific primer corresponded to positions 352–326 (5TGTAGAAACAC
Sigma) for affinity purification of AsP from cell media.CAAAGGTGGCTGTCCA3), and for 3 RACE, the gene-specific
primer corresponded to positions 638–664 (5GACTACGGTGGGAG
TGTCTTGCCAGGA3). Both primers were used with the Marathon Immunoblotting of AsP
The epitope (AsP 23–47) corresponds to the N-terminal peptide ofanchor primer AP1 (5CCATCCTAATACGACTCACTATAGGGC3).
Reactions were set up and cycled as recommended by the kit manu- AsP, which, in some members of this family, is cleaved and remains
attached to the protease by a disulfide bridge. We investigated thisfacturer. The products were analyzed by agarose gel electrophore-
sis, cloned, and sequenced. by separating samples on either reducing or nonreducing gels. Tris-
glycine SDS-PAGE gels (16%) were run and transferred to PVDFOnce the 5 and 3 ends had been determined, the entire full-
Cloning of a Mitogenic Adrenal Serine Protease
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membrane by semi-dry blotting. AsP was detected using a 1:1000 MCA (Sigma), and an internally quenched fluorescent substrate Abz-
LTENPRKYVMJS, designated QFS-20, where the J is nitrotyrosinedilution of the affinity-purified polyclonal AsP antibody followed by
a secondary goat anti-rabbit antibody coupled to HRP and chemilu- and Abz is 2-aminobenzoyl. The structure of QFS-20 (analagous to
POMC [44–55]) was designed to encompass the dibasic Arg/Lysminescence (Pierce). Nonspecific binding was determined by prein-
cubation of the antibody with 100 g of AsP (23–47) for 30 min prior residues at positions 49/50 and was synthesized as previously de-
scribed (Lazure et al., 1998). All peptides were used at a concentra-to addition to the blot.
tion of 20 nM in a volume of 1 ml. They were incubated on the cells
for 2 hr at 37	C before the measurement of fluorescence (For MCASense and Antisense Constructs
peptides, an excitation wavelength of 366 nm and emission wave-The 461 bp AsP fragment amplified by the internal gene-specific
length of 460 nm were used; for QFS-20, an excitation of 340 nmprimers was cloned into pcDNA3.1 (Invitrogen) in either orientation
and emission of 420 nm were used). Activity was standardized toand used to transfect Y1 cells using Effectene reagent (Qiagen).
total cellular protein content.Stable clones were isolated by their resistance to G418 and tran-
scription of the mRNA confirmed using PCR with one gene-specific
primer and one vector-specific primer. Confirmation of decreased Affinity Purification of AsP from Cell Media
AsP protein expression was achieved using Western blotting. Cells Y1 wild-type cells were grown to 70% confluence in 500 cm2 triple
were maintained in normal growth media and growth experiments layer flasks at which time the media was exchanged for Optimem.
carried out in 5% Optimem media as described for the protease The cells were grown for a further 48 hr before the media was
inhibitor experiments. harvested and filtered before affinity purification of AsP by passing
400 ml of media (equivalent to three flasks) through a column con-
taining 250 g of AsP antibody coupled to Sepharose. As a control,Depletion of -MSH Peptides from Cell Media
unconditioned media was passed through the column. FollowingOptimem media was depleted of peptides containing -MSH pep-
extensive washing with saline, AsP activity was detected directlytides using a sheep anti-1-MSH antibody that recognizes both pro-
on the column for its ability to cleave the N-POMC substrate QFS--MSH and 3-MSH (Saphier et al., 1993). Immunoglobulins were
20. The peptide was applied in a volume 1 ml of PBS at a finalprecipitated from either -MSH antiserum or normal sheep serum
concentration of 1.5 M, mixed with the resin, and incubated at(NSS) diluted 1:5 with saline by dissolving solid sodium sulfate to
room temperature for 20 min before fluorescent measurement. Thea final concentration of 18% (w/v), and 50 mg of the resulting IgG
cleaved peptides were concentrated on a C18 ZipTip (Millipore)was coupled to 1 gm of cyanogen bromide activated Sepharose 4B
eluted with 50% acteonitrile/0.1% TFA and dried down for mass(Sigma). Optimem media (10 ml) was passed either through a column
spectral analysis by MALDI-TOF/MS using a Voyager-DE masscontaining the anti--MSH IgG Sepharose (-MSH depleted) or NSS
spectrometer (Applied Biosystems). Finally, the bound enzyme wasIgG Sepharose (control). The resulting media was passed through
eluted from the antibody with 50 mM ammonium formate/acetatea 0.22 m filter and diluted to 5% in MEM for use in growth experi-
buffer (pH 3.5) containing 20% acetonitrile, dried down, and ana-ments.
lyzed by SDS-PAGE and Western blotting.
Molecular Modeling and Immunocytochemistry of AsP
Statistical Analysisin Y1 Cells
In all experiments, values are presented as means with their accom-A model structure for the protein was generated based on its homol-
panying standard errors and statistical differences calculated usingogy with other serine proteases. A multiple sequence alignment was
Student’s t test for unpaired data.generated using the program ClustalW. The model was calculated
using trypsin (38% identity) as the parent structure. For two loops
in the structure, chymotrypsin was used as a closer relative. The Acknowledgments
model was calculated using Quanta and minimized using Quanta
and Insight. The Procheck program was used to show that the The authors acknowledge the support of the Wellcome Trust. ABB
geometry of the final model compared favorably with X-ray crystal is currently the holder of the Marjorie Robinson Memorial Fellowship
structures. awarded by the Society for Endocrinology.
To determine the cellular location of AsP, we performed immuno-
cytochemistry on sense and antisense cells with the anti-AsP anti- Received December 26, 2000; revised May 29, 2001.
body. To avoid penetration of the cells by the antisera, detergents
were omitted from all buffers. Transfected Y1 cells were grown on
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